SCNI — Scinai Immunotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Scinai Immunotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	10-K	20-F	20-F
Standards:	IFRS	IFRS	USG	USG	USG
Status:	fx Final	fx Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.93	17.4	14.1	4.87	1.96
Net Total Accounts Receivable
Net Total Receivables	0.375	0.326	—	—	0.083
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3.31	17.7	14.4	5.45	2.39
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	14.3	14.2	12.7	12	11.1
Other Long Term Assets
Total Assets	17.7	32.1	27.1	17.5	13.4
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20	2.32	2.34	1.78	1.81
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.3	24.6	28.8	22	3.47
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-4.55	7.52	-1.76	-4.57	9.98
Total Liabilities & Shareholders' Equity	17.7	32.1	27.1	17.5	13.4
Total Common Shares Outstanding